Market Highlights
Minimally invasive procedures are now being preferred by the healthcare provider and the patients. Gastric bypass is one of the bariatric surgical procedures used to treat obesity across the globe.
Additionally, the progress of medical device industry in developed regions across the globe also influences the demand for surgical devices. Diabetes and obesity are the major risk factors for the cardiovascular disease, whose prevalence is found to be increasing from last few years.
The global gastric bypass market is expected to grow at a CAGR of 6.1 % during the forecast period 2017-2023.
https://www.marketresearchfuture.com/reports/gastric-bypass-market-5321
Segmentation
The global gastric bypass market is segmented on the basis of type, indication, and end user. On the basis of type, it is segmented into endoscopic sleeve gastroplasty and intragastric balloon.
Based on the indication, it is segmented into obesity, gastroesophageal reflux disease, heart disease, high blood pressure, type 2 diabetes, and others. On the basis of the end user, it is segmented into hospitals & clinics, surgical centers, and others.
In the Middle East & Africa, the market exhibits steady owing to low technology penetration in developing regions, and focus on primary care services. The United Arab Emirates (UAE), Saudi Arabia, and Kuwait are expected to drive the Middle East & African market. Whereas, the African region is expected to witness a moderate growth.
Key Players
Some of key the players in the market are Medtronic (U.S.), Intuitive Surgical Inc. (U.S.), TransEnterix Inc. (U.S.), ALLERGAN (Republic of Ireland), USGI Medical Inc. (U.S.), Cousin Biotech (France), GI Dynamics Inc. (U.S.), Johnson & Johnson Services, Inc. (U.S.), Mediflex Surgical Product (U.S.), and others.